Pspp - identification and validation of novel pain related endpoints, novel animal models of pain and profiling of investigational agents in rodent and non-rodent [excluding (NHP)] species
Ended Awarded Last action
- Contract number
- 75N95019F00089
- Awardee
-
Psychogenics Inc. UEI YXMNA8N7LFG4
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,848,873
Award facts
- Opportunity
-
- Screening of Investigational Agents through the NINDS Preclinical Screening Platform for Pain (PSPP) Pre-Solicitation · NIHNINDS75N95019R00027 · Posted Jan 30, 2019
- Screening of Investigational Agents through the "NINDS Preclinical Screening Platform for Pain" (PSPP) Award Notice · Posted Mar 27, 2019
- Contract value 100% obligated
- $1,848,873.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Institute of Neurological Disorders and Stroke National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Paramus, NJ 07652, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$1,275,889 | |
| Original award | $3,124,762 |
About this award
Psychogenics Inc. was awarded a $1.8 million cost-plus-fixed-fee delivery order contract by the National Institute of Neurological Disorders and Stroke to support the Preclinical Screening Platform for Pain program. Under this contract, Psychogenics will provide identification and validation of novel pain-related endpoints and animal models of pain, as well as profiling of investigational agents in rodent and non-rodent species excluding non-human primates. This delivery order was issued against the National Institutes of Health Information Technology Acquisition and Assessment Center GWAC vehicle and does not have a set-aside designation. Work will be performed by Psychogenics in Paramus, New Jersey over a five-year period ending in September 2024.
Quick answers
Who was awarded contract 75N95019F00089?
75N95019F00089 was awarded to Psychogenics Inc. by National Institute on Drug Abuse (National Institutes of Health) on September 27, 2019.
How much is contract 75N95019F00089 worth?
The government has obligated $1,848,873 on 75N95019F00089.
Which agency awarded contract 75N95019F00089?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95019F00089, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).
Is contract 75N95019F00089 an order under another contract?
Yes. 75N95019F00089 is a delivery order under 75N95019D00026, an indefinite delivery contract.
Was contract 75N95019F00089 competed?
The extent of competition for 75N95019F00089 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award